SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104. A total of 117 filers reported holding SCICLONE PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 1.71 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2014 | $91,000 | -34.1% | 10,360 | -48.4% | 0.08% | -45.5% |
Q3 2014 | $138,000 | +29.0% | 20,060 | -1.6% | 0.14% | +59.3% |
Q2 2014 | $107,000 | +87.7% | 20,376 | +80.8% | 0.09% | -19.5% |
Q4 2013 | $57,000 | -6.6% | 11,272 | -8.0% | 0.11% | -41.8% |
Q2 2013 | $61,000 | – | 12,255 | – | 0.19% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 1,663,281 | $16,300,000 | 9.19% |
Nantahala Capital Management | 1,891,328 | $18,535,000 | 2.06% |
Nine Chapters Capital Management LLC | 40,700 | $399,000 | 0.54% |
MENTA CAPITAL LLC | 396,336 | $3,884,000 | 0.38% |
Sapphire Star Partners LP | 30,439 | $298,000 | 0.34% |
TFS CAPITAL LLC | 95,432 | $935,000 | 0.30% |
Ativo Capital Management LLC | 123,428 | $1,210,000 | 0.30% |
GLG Partners LP | 363,188 | $3,559,000 | 0.17% |
GSA CAPITAL PARTNERS LLP | 240,013 | $2,352,000 | 0.13% |
Bowling Portfolio Management LLC | 68,473 | $671,000 | 0.11% |